quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
for the management of	153
guidelines for the management	132
in the united states	124
acquired pneumonia in adults	99
e times a day	94
infectious diseases society of	89
diseases society of america	88
severe acute respiratory syndrome	87
for the treatment of	83
the management of community	81
acute respiratory distress syndrome	79
lower respiratory tract infections	75
in the treatment of	74
for the diagnosis of	71
systematic review and meta	64
is the most common	63
the diagnosis of pneumonia	60
in patients with severe	60
chronic obstructive pulmonary disease	60
on the basis of	60
lower respiratory tract infection	59
g e times a	58
at the time of	57
as a result of	56
it is important to	56
mg kg times a	52
kg times a day	51
in patients with community	50
in the absence of	50
mg twice a day	50
a systematic review and	49
the lower respiratory tract	48
the intensive care unit	46
one of the most	46
in the diagnosis of	45
is one of the	45
of pneumonia in children	43
drugs to be recommended	42
the infectious diseases society	42
acquired pneumonia in children	42
of lower respiratory tract	40
of community acquired pneumonia	40
as a cause of	40
of the respiratory tract	40
disease control and prevention	39
influenza a and b	39
for disease control and	38
than years of age	38
children younger than years	37
acquired pneumonia in the	37
management of adults with	36
of patients with cap	36
patients with severe cap	36
on the other hand	36
centers for disease control	36
can be used to	35
community acquired pneumonia in	35
in patients with cap	35
the upper respiratory tract	34
in the presence of	34
respiratory tract infections in	33
of severe acute respiratory	33
patients with severe pneumonia	32
efficacy and safety of	32
in the management of	32
mg once a day	32
antimicrobial drugs should be	32
in patients with pneumonia	31
in up to of	31
america american thoracic society	31
society of america american	31
in the intensive care	31
of america american thoracic	31
influenza a h n	31
diagnosis of pneumonia in	30
the most common cause	30
in children younger than	30
white blood cell count	30
under years of age	30
on the management of	29
the guidelines for the	29
most common cause of	29
detection of streptococcus pneumoniae	29
of type ii pneumonocytes	28
diagnosis and management of	28
should be considered in	28
has been shown to	28
the management of respiratory	28
in children with pneumonia	27
e g e times	27
of morbidity and mortality	27
management of patients with	27
haemophilus influenzae type b	27
acquired pneumonia requiring hospitalization	26
guidelines on the management	26
of the most common	26
of pneumonia in the	26
in infants and children	26
middle east respiratory syndrome	26
consensus guidelines on the	26
valent pneumococcal conjugate vaccine	26
thoracic society consensus guidelines	26
children under years of	26
intravenous injection or drip	25
in the setting of	25
society consensus guidelines on	25
are similar to those	25
the japanese respiratory society	25
in patients with chronic	25
american thoracic society consensus	25
patients admitted to the	24
kg once a day	24
after the onset of	24
the centers for disease	24
than months of age	24
in a patient with	24
mg kg once a	24
leading cause of death	23
clinical practice guidelines by	23
with respect to the	23
admitted to the hospital	23
the onset of symptoms	23
by the presence of	23
management of community acquired	23
in the course of	23
infants and young children	23
invasive pneumococcal disease in	23
mortality in patients with	23
of respiratory infectious diseases	23
acute igg als to	23
practice guidelines by the	23
in hospitalized patients with	23
in addition to the	22
the presence of a	22
of patients with community	22
of the lower respiratory	22
patients hospitalized with community	22
of communityacquired pneumonia in	22
an increase in the	22
length of hospital stay	22
and the presence of	22
years of age in	22
hyperplasia of type ii	22
the world health organization	22
the management of adults	22
review of the literature	22
in accordance with the	22
acquired pneumonia in hospitalized	21
respiratory tract infection in	21
are the most common	21
of respiratory syncytial virus	21
for the prevention of	21
of invasive pneumococcal disease	21
the leading cause of	21
with community acquired pneumonia	21
may be associated with	21
of adults with hospital	21
diagnosis of pneumococcal pneumonia	21
a randomized controlled trial	21
should be considered for	21
and respiratory syncytial virus	21
lower respiratory tract disease	21
als to pneumococcal proteins	21
an important cause of	21
presence or absence of	21
the etiology of pneumonia	21
g iv q h	21
in the era of	21
in patients with a	21
in the differential diagnosis	20
should be combined with	20
for the detection of	20
similar to those of	20
in the immunocompromised host	20
g times a day	20
more likely to have	20
pneumonia in patients with	20
cause of death in	20
critical review of the	20
in critically ill patients	20
pneumonia in the elderly	20
been shown to be	20
society guidelines for the	20
management of respiratory infectious	19
conception and design of	19
in the context of	19
and design of study	19
morbidity and mortality in	19
to the development of	19
a common cause of	19
contributed to conception and	19
respiratory syncytial virus infection	19
it is difficult to	19
kg twice a day	19
and critical review of	19
streptococcus pneumoniae urinary antigen	19
elderly patients with pneumonia	19
review of the manuscript	19
drugs should be selected	19
the american thoracic society	19
admitted to the icu	19
in which there is	19
mg kg twice a	19
respiratory infectious diseases in	19
a prospective study of	19
to conception and design	19
less than years of	19
the british thoracic society	18
the differential diagnosis of	18
was approved by the	18
of the nasal cavity	18
in dogs and cats	18
be considered in the	18
of patients hospitalized with	18
and lower respiratory tract	18
a large number of	18
igg als to pneumococcal	18
more likely to be	18
adult respiratory distress syndrome	18
is characterized by a	18
for detection of streptococcus	18
an increased risk of	18
infectious diseases in children	18
a risk factor for	18
of patients with severe	18
the presence or absence	17
east respiratory syndrome coronavirus	17
for patients with severe	17
in patients who have	17
respiratory syncytial virus in	17
of childhood pneumonia in	17
the development of pneumonia	17
an important role in	17
practice guidelines for the	17
were more likely to	17
risk of resistant bacteria	17
in patients who are	17
intensive care unit admission	17
children with pneumococcal pneumonia	17
of pneumonia and influenza	17
has been associated with	17
the global burden of	17
the nasal cavity and	17
should not be used	17
a day second choices	17
diagnosis and treatment of	17
risk patients with community	17
in the lower lobes	17
the presence of an	16
critically ill patients with	16
based on the results	16
was associated with a	16
it should be noted	16
have been associated with	16
pneumonia in hospitalized patients	16
refer to the section	16
in patients with acute	16
in adult patients with	16
bone marrow transplant recipients	16
of patients with pneumonia	16
studies have shown that	16
caused by streptococcus pneumoniae	16
patients with severe community	16
in the case of	16
by the infectious diseases	16
acute respiratory syndrome coronavirus	16
the incidence of pneumonia	16
children less than years	16
with lower respiratory tract	16
during an influenza pandemic	16
is a risk of	16
of hospitalized patients with	16
combination therapy with a	16
can be seen in	16
risk factors for infection	16
in the pathogenesis of	16
are more likely to	16
infection in patients with	16
of chronic obstructive pulmonary	16
pneumonia is characterized by	16
patients with communityacquired pneumonia	16
should be treated with	16
children years of age	16
patients with cystic fibrosis	16
there is a risk	16
to a lesser extent	16
one of the following	16
the early stages of	16
of pneumonia caused by	16
pneumonia requiring hospitalization among	16
mg e times a	15
with chronic respiratory disease	15
the most common causes	15
gram stain and culture	15
it is possible that	15
cause of morbidity and	15
multiplex polymerase chain reaction	15
mean roc auc score	15
etiology of childhood pneumonia	15
pneumonia in hospitalized children	15
children with severe pneumonia	15
in elderly patients with	15
pneumonia in the intensive	15
with bacteremic pneumococcal pneumonia	15
infectious disease society of	15
the risk of death	15
in intensive care units	15
samples from patients with	15
the presence of pneumonia	15
cases in which there	15
in the development of	15
in the incidence of	15
in the emergency department	15
the management of hospital	15
disease society of america	15
sepsis and septic shock	15
is associated with a	15
one of the followings	15
an intensive care unit	15
clinical signs and symptoms	15
is the leading cause	15
etiology of pneumonia in	15
has been reported in	15
in this age group	15
duration of mechanical ventilation	15
pneumonia and influenza deaths	15
at high risk of	15
antimicrobial drug should be	15
at the same time	14
hospitalized patients with cap	14
severe sepsis and septic	14
similar to that of	14
increased risk of death	14
a randomized clinical trial	14
of influenza a and	14
for the development of	14
should be noted that	14
the use of a	14
it is necessary to	14
global burden of disease	14
need for mechanical ventilation	14
in a prospective study	14
administration of antimicrobial drugs	14
the course of the	14
have been shown to	14
patients with pneumonia were	14
a prediction rule to	14
incidence of pneumonia in	14
can be caused by	14
japanese respiratory society guidelines	14
patients with bacteremic pneumococcal	14
of severe pneumonia in	14
with risk factors for	14
in the current study	14
in patients admitted to	14
from intravenous to oral	14
have been reported in	14
of adults with community	14
admitted to hospital with	14
to be associated with	14
patients with chronic respiratory	14
frequency of causative microorganisms	14
the pneumonia severity index	14
as well as in	14
the severity of the	14
patients with cap who	14
the most common pathogens	14
most common causes of	14
younger than years of	14
the treatment of community	14
prediction rule to identify	14
with the exception of	14
to the intensive care	14
factors for infection with	14
of children with pneumonia	14
on the results of	14
pneumoniae is the most	14
in patients with aids	14
bacterial and viral pneumonia	13
a major cause of	13
requiring hospitalization among u	13
valent pneumococcal polysaccharide vaccine	13
pneumonia requiring intensive care	13
in the outpatient setting	13
outcomes of patients with	13
requiring intensive care unit	13
in the upper respiratory	13
the acute respiratory distress	13
with a history of	13
pour le diagnostic des	13
as a consequence of	13
assay for detection of	13
cause of pneumonia in	13
of the most important	13
in children and adults	13
management of communityacquired pneumonia	13
and frequency of causative	13
pneumococcal pneumonia and non	13
of antimicrobial drug therapy	13
there is no evidence	13
guidelines by the infectious	13
of the upper respiratory	13
it is likely that	13
patients who do not	13
patients with viral pneumonia	13
a and b viruses	13
a systematic review of	13
be the result of	13
the nature of the	13
or more of the	13
of the lung parenchyma	13
as well as the	13
burden of disease study	13
in the present study	13
patients with risk factors	13
outcomes in patients with	13
was the most common	13
type and frequency of	13
to be the most	13
acute lower respiratory tract	13
during the course of	13
for the use of	13
herpes simplex virus pneumonia	13
of america and the	12
advisory committee on immunization	12
the idsa ats guidelines	12
mean roc auc scores	12
patients admitted to hospital	12
to the hospital with	12
patients with community acquired	12
one or more of	12
are at risk for	12
pneumococcal conjugate vaccine in	12
in lower respiratory tract	12
the most common bacterial	12
therapy in patients with	12
rule to identify low	12
of all cases of	12
and acute respiratory distress	12
diseases society and the	12
a prospective observational study	12
has been reported to	12
and risk factors for	12
can be found in	12
as part of a	12
fluid total wbc count	12
the microbial etiology of	12
a day or g	12
detection of respiratory viruses	12
the diagnosis and management	12
in the form of	12
polymerase chain reaction for	12
and the infectious diseases	12
rules of antimicrobial drug	12
pneumonia is a common	12
syncytial virus infection in	12
as part of the	12
bal fluid total wbc	12
as the presence of	12
the surface of the	12
are listed in table	12
in the respiratory tract	12
been reported to be	12
in those with severe	12
society of america and	12
infections of the lung	12
in the nasal cavity	12
from the lower respiratory	12
lower respiratory infections in	12
with avian influenza a	12
is more common in	12
infectious diseases society and	12
acquired pneumonia due to	12
such as pseudomonas aeruginosa	12
in the lungs of	12
with the use of	12
a small number of	12
committee on immunization practices	12
be considered in patients	12
g once a day	12
of severe sepsis and	12
the absence of a	12
g twice a day	12
of risk factors for	12
the severity of illness	12
receptor expressed on myeloid	11
the age of the	11
the management of patients	11
up to of patients	11
the initial management of	11
to respiratory syncytial virus	11
as well as a	11
acquired pneumonia severity on	11
the treatment of cap	11
a clinical diagnosis of	11
of the lower lobes	11
is a common cause	11
on presentation to hospital	11
pneumonia in adults in	11
administration period of antimicrobial	11
triggering receptor expressed on	11
in children under years	11
the united states and	11
acquired pneumonia in patients	11
the duration of therapy	11
of the incidence of	11
respiratory society guidelines for	11
binax now streptococcus pneumoniae	11
pneumonia severity on presentation	11
cirrhotic patients with pneumonia	11
of the alveolar walls	11
an international derivation and	11
pneumoniae urinary antigen test	11
by the pediatric infectious	11
infection of the lung	11
a wide variety of	11
diagnosis of bacterial pneumonia	11
e g times a	11
diagnosis of pneumonia is	11
in children less than	11
may be seen in	11
is based on the	11
pneumonia in elderly patients	11
acute respiratory tract infections	11
la prise en charge	11
should also be considered	11
pneumonia is one of	11
of the presence of	11
of the trachea and	11
the authors declare that	11
viral infections of the	11
in the thoracic cavity	11
on the th day	11
international derivation and validation	11
of patients with an	11
burden of childhood pneumonia	11
increase the risk of	11
the diagnosis of pneumococcal	11
thoracic society guidelines for	11
respiratory tract infections and	11
intensive care unit patients	11
it is estimated that	11
on the pleural surface	11
in patients with suspected	11
have been developed to	11
respiratory tract infections are	11
in infants and young	11
clinical management of patients	11
expressed on myeloid cells	11
during the study period	11
pneumonia in infants and	11
of aspiration pneumonia in	11
considered in the differential	11
for the identification of	11
in invasive pneumococcal disease	11
the clinical features of	11
in adults and children	11
of respiratory tract infection	11
in the early stages	11
is an important cause	11
hospitalized patients with community	11
period of antimicrobial drugs	11
of children under years	11
should be used for	11
patients with pneumococcal bacteremia	11
and in those with	11
the most common pathogen	11
in adults hospitalized with	11
the burden of pneumonia	11
the risk of pneumonia	11
treatment in patients with	11
upper and lower respiratory	11
in children with severe	11
in patients in whom	11
derivation and validation study	11
in the section on	11
children older than months	11
soluble triggering receptor expressed	11
bts guidelines for the	11
children under five years	11
severity on presentation to	11
both lower lung fields	10
highest mean roc auc	10
the majority of patients	10
the right lower lobe	10
to the use of	10
of pneumococcal pneumonia in	10
the pediatric infectious diseases	10
illness during an influenza	10
most commonly caused by	10
in the general population	10
an infection of the	10
and review of the	10
pediatric infectious diseases society	10
a limited number of	10
patients with acute respiratory	10
patients with severe sepsis	10
children in developing countries	10
up to of cases	10
kg e times a	10
should be considered when	10
patients with and without	10
therapy with a b	10
in mechanically ventilated patients	10
and outcomes of patients	10
in intensive care unit	10
the prevention of ventilator	10
play an important role	10
can be divided into	10
and clinical characteristics of	10
of the respiratory system	10
with chronic lung disease	10
severe pneumonia requiring intensive	10
are presented in table	10
older than months of	10
with increased risk of	10
be taken into account	10
in children aged years	10
a wide range of	10
the clinical presentation of	10
children and young adults	10
years of age and	10
adults hospitalized with community	10
respiratory tract disease in	10
no risk factors for	10
infants and children older	10
the administration period of	10
patients with suspected pneumonia	10
of death in children	10
the first hours of	10
viral and bacterial pneumonia	10
pneumonia incidence and mortality	10
should be selected in	10
like illness during an	10
pneumococcal pneumonia in children	10
and the risk of	10
on the presence of	10
of this study was	10
respiratory infections in children	10
with acute respiratory failure	10
acute lower respiratory infection	10
the management of communityacquired	10
society and the infectious	10
characterized by the presence	10
patients with septic shock	10
who are severely ill	10
pneumonia and influenza cases	10
which there is a	10
can be present in	10
hematopoietic stem cell transplantation	10
been found to be	10
beyond the scope of	10
in all age groups	10
ct findings in patients	10
among adults hospitalized with	10
mg kg e times	10
the rest of the	10
at increased risk of	10
community acquired pneumonia severity	10
a leading cause of	10
considered in patients with	10
that they have no	10
is characterized by the	10
consent was obtained from	10
study was approved by	10
acute lower respiratory infections	10
and national causes of	10
and children older than	10
guidelines for management of	10
in the perch study	10
were found to be	10
pneumonia in immunocompetent adults	10
the management of cap	10
associated with influenza a	10
the administration of antimicrobial	10
of the severity of	10
respiratory syncytial virus infections	10
therapy for patients with	10
patients with an influenza	10
is likely to be	10
are present in the	10
in of patients with	10
of influenza a virus	10
the results of the	10
for the diagnosis and	10
resolution ct findings in	10
may or may not	10
into the pleural space	10
times a day second	10
avian influenza a h	10
the vast majority of	10
canine infectious respiratory disease	10
children with bacterial pneumonia	10
days after the onset	10
time polymerase chain reaction	10
studies have suggested that	10
admitted to the intensive	10
mg times a day	9
such as streptococcus pneumoniae	9
the severity of disease	9
defining community acquired pneumonia	9
adult patients with community	9
there was no difference	9
the trachea and bronchi	9
as a complication of	9
of the interlobular septa	9
definite other bacterial pneumonia	9
and factors associated with	9
pneumonia in developing countries	9
due to respiratory syncytial	9
in community acquired pneumonia	9
authors declare that they	9
times a day or	9
pneumonia in critically ill	9
of randomized controlled trials	9
with regard to the	9
pediatric intensive care unit	9
acquired pneumonia caused by	9
of a patient with	9
the etiology of cap	9
the drug of choice	9
tablets e times a	9
in patients with covid	9
mortality for patients with	9
is referred to as	9
of pneumococcal conjugate vaccination	9
pneumonia is defined as	9
the thorax is opened	9
pneumonia is the leading	9
drug should be selected	9
the treatment of pneumonia	9
five years of age	9
associated with increased risk	9
risk factors for pneumonia	9
respiratory or vasopressor support	9
the scope of this	9
and years of age	9
in a child with	9
with the development of	9
be selected in accordance	9
has also been reported	9
pneumonia caused by streptococcus	9
if the patient is	9
years of age with	9
the primary cause of	9
and an increase in	9
drugs should be administered	9
acquired pneumonia in adult	9
pneumonia etiology in children	9
of respiratory viruses in	9
one of the above	9
aged years or older	9
in about of cases	9
risk factors for severe	9
use of antimicrobial drugs	9
are likely to be	9
under five years of	9
segments of the lower	9
urinary antigen test for	9
in a nursing home	9
nasal cavity and paranasal	9
if the patient has	9
important role in the	9
as many as of	9
communityacquired pneumonia in adults	9
committee for the japanese	9
infections of the lower	9
aspiration of gastric contents	9
who do not have	9
also referred to as	9
and pleuritic chest pain	9
selected in accordance with	9
acquired pneumonia in immunocompetent	9
influenza a virus infection	9
a h n virus	9
were significantly higher in	9
a systematic analysis for	9
analysis of children under	9
in the diagnosis and	9
see the section on	9
that the use of	9
may be accompanied by	9
and economic burden of	9
microbial etiology of pneumonia	9
in the developing world	9
respiratory syncytial virus and	9
pneumococcal pneumonia in adults	9
and the united states	9
caused by mycoplasma pneumoniae	9
should be administered for	9
with severe pneumonia requiring	9
of acute lower respiratory	9
epidemiology and etiology of	9
analysis for the global	9
for diagnosis of pneumococcal	9
the management of pneumonia	9
further studies are needed	9
and management of community	9
children aged years or	9
systematic analysis for the	9
may be suboptimal for	9
of bacterial pneumonia in	9
for hospitalized patients with	9
can also be seen	9
of empyema in children	9
with pneumococcal pneumonia and	9
of antibiotic therapy for	9
risk factors for mdr	9
early in the course	9
and etiology of childhood	9
more common in the	9
and the use of	9
for adults and children	9
associated with increased mortality	9
antigen in urine samples	9
of practice guidelines for	9
for lower respiratory tract	9
cavity and paranasal sinuses	9
should be performed in	9
same dose for adults	9
the use of the	9
now streptococcus pneumoniae urinary	9
culture and antimicrobial susceptibility	9
in patients hospitalized with	9
burden of pneumonia in	9
streptococcus pneumoniae is the	9
drugs should be combined	9
cultures are positive in	9
for the global burden	9
all patients with cap	9
the proportion of patients	9
the number of patients	9
principles and practice of	9
of the immune system	9
treatment of patients with	9
play a role in	9
a diagnosis of pneumonia	9
of streptococcus pneumoniae and	9
the central nervous system	9
the radiographic features of	9
is the result of	9
in the guidelines for	9
update of practice guidelines	9
group than in the	9
dose for adults and	9
the binax now streptococcus	9
signs and symptoms of	9
it is impossible to	9
declare that they have	9
an influenza pandemic s	9
in a recent study	9
in the united kingdom	9
may be caused by	9
a review of the	9
the basis of the	9
in patients with cystic	9
is not necessary to	9
the treatment of patients	9
younger than months of	9
guidelines by the pediatric	9
a study reported that	9
addition to the above	8
causes of child mortality	8
the source of infection	8
risk of death and	8
twice a day second	8
the use of this	8
course of the disease	8
in the pediatric population	8
lactam and a macrolide	8
predicting the need for	8
it is caused by	8
pneumonia in children in	8
and characteristics of viral	8
for more than hours	8
of streptococcus pneumoniae urinary	8
informed consent was obtained	8
the widespread use of	8
to mm in diameter	8
be used as a	8
r n a l	8
samples from adults with	8
upper respiratory tract symptoms	8
of the disease is	8
the portal of entry	8
and is associated with	8
of children with severe	8
once a day or	8
to occur in the	8
pneumococcal conjugate vaccine on	8
prevention and control of	8
respiratory pathogens in community	8
the committee for the	8
pneumonia was defined as	8
high index of suspicion	8
for rapid detection of	8
may be present in	8
are shown in table	8
national causes of child	8
pulmonary edema and emphysema	8
the advisory committee on	8
in the left lower	8
since the introduction of	8
etiology research for child	8
from patients with pneumonia	8
pneumonia among children aged	8
the etiologic diagnosis of	8
risk factors for drsp	8
chest radiographs for the	8
is the most important	8
intubation and mechanical ventilation	8
respiratory viral infections in	8
radiographs for the diagnosis	8
the infectious disease society	8
this drug should be	8
with an increased risk	8
should be given to	8
the first days of	8
invasive pneumococcal disease among	8
adult lower respiratory tract	8
do not respond to	8
on the severity of	8
and haemophilus influenzae type	8
j o u r	8
the clinical characteristics of	8
a high proportion of	8
of respiratory tract infections	8
the clinical management of	8
the left upper lobe	8
be caused by a	8
as chronic obstructive pulmonary	8
for the initial management	8
and influenza a virus	8
np carriage of pneumococci	8
such as chronic obstructive	8
a preliminary randomized study	8
interpretation of chest radiographs	8
of the conducting system	8
with human immunodeficiency virus	8
treatment of severe pneumonia	8
they have no competing	8
is also associated with	8
upper respiratory tract infection	8
severe community acquired pneumonia	8
of bacteremic pneumococcal pneumonia	8
o u r n	8
in cases of severe	8
patients with suspected vap	8
in the initial phase	8
outcomes in elderly patients	8
a day for days	8
from the perspective of	8
in cases in which	8
in the upper lobes	8
increase the likelihood of	8
is considered to be	8
upper respiratory tract infections	8
on a chest radiograph	8
infusion for severe community	8
acquired in the community	8
findings in patients with	8
are at increased risk	8
is the presence of	8
of patients admitted to	8
studies are needed to	8
the diagnosis and treatment	8
patients with pneumonia in	8
as the cause of	8
is primarily caused by	8
patients with pneumococcal pneumonia	8
to an intensive care	8
with acute respiratory illness	8
in the prevention of	8
prospective study of the	8
safety and efficacy of	8
chronic obstructive lung disease	8
the upper and lower	8
intensive respiratory or vasopressor	8
childhood pneumonia and diarrhoea	8
also be seen in	8
from the respiratory tract	8
the severity of pneumonia	8
antibiotic therapy in the	8
a high index of	8
of the pulmonary parenchyma	8
aspiration pneumonitis and aspiration	8
number of patients with	8
studies of patients with	8
most frequent cause of	8
guidelines for the initial	8
superior segment of the	8
a member of the	8
and in patients with	8
antimicrobial drug therapy should	8
lactam plus a macrolide	8
is the most commonly	8
is caused by a	8
most common in the	8
in patients hospitalized for	8
alveoli are filled with	8
of viral pneumonia is	8
between the two groups	8
u r n a	8
must be considered in	8
the highest mean roc	8
british thoracic society guidelines	8
has not been established	8
a randomised controlled trial	8
viral infection in patients	8
diagnosis of aspiration pneumonia	8
a mortality rate of	8
research for child health	8
infants and children with	8
the need for icu	8
with moderate to severe	8
pneumonia etiology research for	8
respect to the administration	8
pneumonia in older adults	8
pneumonia in the era	8
may be useful in	8
management of severe sepsis	8
switch from intravenous to	8
of streptococcus pneumoniae antigen	8
in the majority of	8
in previously healthy children	8
in bone marrow transplant	8
been associated with a	8
that there was no	8
an appropriate antimicrobial drug	8
based on the presence	8
proportion of patients with	8
characteristics of viral community	8
in vitro and in	8
pneumonitis and aspiration pneumonia	8
incidence and characteristics of	8
hydrocortisone infusion for severe	8
patients with severe covid	8
to prepare the guidelines	8
the clinical effects of	8
in cirrhotic patients with	8
nucleic acid amplification tests	8
to the severity of	8
the immune response to	8
admission to the icu	8
the polymerase chain reaction	8
should be collected and	8
has been described in	8
the pneumococcal conjugate vaccine	8
for the japanese respiratory	8
from adults with community	8
not appear to be	8
analysis of bal fluid	8
are associated with a	8
sensitivity and specificity of	8
not included in the	8
is also a common	8
pneumonia is associated with	8
to secondary bacterial pneumonia	8
the periphery of the	8
aged years or younger	8
time to clinical stability	8
to confirm the diagnosis	8
of bacterial and viral	8
in the pleural space	8
the causative agent of	8
major cause of morbidity	8
the impact of the	8
associated pneumonia in adults	8
to the emergency department	8
e mg kg times	8
patients with cap and	8
have no competing interests	8
the host immune response	7
the treatment of severe	7
pneumonia is demonstrated as	7
is clinically characterized by	7
the systemic inflammatory response	7
has been found to	7
for patients with cap	7
of patients with a	7
treatment should be started	7
in both children and	7
in a patient who	7
study of patients with	7
maternal and child health	7
in collaboration with the	7
patients in whom the	7
is important to note	7
is recommended for patients	7
be included in the	7
or g twice a	7
classification of the disease	7
obtained after an interval	7
is made based on	7
pneumonia continues to be	7
that the incidence of	7
oxygenation completely improved within	7
have been used to	7
a controlled trial of	7
higher in the bacterial	7
use of antibiotics in	7
the respiratory tract in	7
of patients in the	7
time to first antibiotic	7
in severely ill patients	7
were admitted to the	7
deaths from pneumonia per	7
management of pneumonia in	7
high morbidity and mortality	7
pneumoniae and haemophilus influenzae	7
the right middle lobe	7
of secondary bacterial infection	7
patients with pulmonary infiltrates	7
p r o o	7
there was no significant	7
with severe pneumonia in	7
in children older than	7
are at high risk	7
and invasive pneumococcal disease	7
in the lung and	7
clinical and economic burden	7
for intensive respiratory or	7
to cm in diameter	7
be admitted to the	7
a large proportion of	7
patients older than years	7
le diagnostic des infections	7
is similar to that	7
was not associated with	7
cause of death from	7
both children and adults	7
of adults referred to	7
with severe acute respiratory	7
blood cultures are positive	7
no significant differences in	7
bacteremic pneumococcal pneumonia in	7
a role in the	7
a l p r	7
drug therapy should be	7
and management of pneumonia	7
disease in the immunocompromised	7
au cours de la	7
within the first days	7
the left lower lobe	7
no risk of resistant	7
vitro and in vivo	7
clinical risk factors for	7
recommendations of the advisory	7
depending on the stage	7
from patients with severe	7
comprehensive molecular testing for	7
in a series of	7
the use of niv	7
and treatment of pneumonia	7
is more likely to	7
the pleural fl uid	7
are rarely seen in	7
h or more after	7
bacteremia in patients with	7
in the early phase	7
the case fatality rate	7
japanese society of chemotherapy	7
be present in the	7
the number of pneumonia	7
the american journal of	7
and critical care medicine	7
this drug is contraindicated	7
acute respiratory failure in	7
in terms of the	7
in less than of	7
be considered for treatment	7
the introduction of the	7
diagnosis of cap is	7
of the disease process	7
likely to have a	7
a retrospective cohort study	7
is a major cause	7
therapy should be started	7
adults hospitalized with influenza	7
patients with cap admitted	7
may be due to	7
one year of age	7
in the bacterial pneumonia	7
prospective study of patients	7
for management of severe	7
in the viral pneumonia	7
at least one of	7
lower respiratory tract complications	7
are usually associated with	7
a cause of community	7
does not appear to	7
hours after the onset	7
parts of the world	7
similar to that seen	7
acquired pneumonia in infants	7
risk factors for community	7
more of the following	7
failure in patients with	7
enrolled in the study	7
and risk factors of	7
in any of the	7
pneumonia in epidemiological studies	7
to the presence of	7
need for intensive respiratory	7
acquired respiratory tract infections	7
for severe bacteremic pneumococcal	7
admission to an icu	7
a risk of resistant	7
thickening of the alveolar	7
is a highly contagious	7
test for diagnosis of	7
during the early stages	7
of diffuse alveolar damage	7
to the risk of	7
can be used as	7
does this patient have	7
in the field of	7
cellular analysis of bal	7
for respiratory pathogens in	7
management of childhood illness	7
urinary antigen tests for	7
of children hospitalized with	7
criteria for severe cap	7
is most commonly caused	7
for patients with bacteremic	7
small number of patients	7
human metapneumovirus infection in	7
severe bacteremic pneumococcal pneumonia	7
detection by blood pcr	7
may be related to	7
mechanically ventilated patients with	7
children with pneumonia in	7
of streptococcus pneumoniae in	7
pcr pour le diagnostic	7
in those patients who	7
when the thorax is	7
common in patients with	7
by a variety of	7
the etiology of community	7
associated with lower mortality	7
the results obtained in	7
prognosis and outcomes of	7
respiratory failure in patients	7
risk of death from	7
if there is no	7
is most common in	7
of acute igg als	7
in patients with risk	7
the sensitivity and specificity	7
a study indicated that	7
for patients with a	7
in acute respiratory tract	7
l p r e	7
molecular testing for respiratory	7
bronchiolitis obliterans organizing pneumonia	7
viral and bacterial infections	7
centre for disease control	7
in children with underlying	7
of influenza in children	7
the diagnosis of pediatric	7
the case of a	7
in a pandemic situation	7
in the normal host	7
improvement in clinical symptoms	7
an updated systematic analysis	7
use of this drug	7
adult patients admitted to	7
in children and adolescents	7
the middle and lower	7
tract infections in children	7
testing for respiratory pathogens	7
randomized controlled trial of	7
of childhood pneumonia and	7
the diagnosis of community	7
one of the leading	7
associated with pneumonia in	7
are summarized in table	7
the chest radiograph in	7
identify pneumonia and influenza	7
the time of admission	7
be seen in the	7
with a reduction in	7
incidence of side effects	7
of the onset of	7
in writing the manuscript	7
duration of antimicrobial therapy	7
the treatment of hospitalized	7
viruses were detected in	7
is an infection of	7
of the patients with	7
as a pathogen in	7
mycoplasma pneumoniae and chlamydia	7
mycoplasma pneumoniae infection in	7
lower respiratory tract specimens	7
among children under five	7
can be used for	7
patients with severe sars	7
in sheep and goats	7
patients who have been	7
to nm in diameter	7
differentiation of bacterial and	7
recommended for patients with	7
of the advisory committee	7
early switch from intravenous	7
accordance with the section	7
in patients with bacterial	7
parapneumonic effusions in children	7
the clinical presentation and	7
n a l p	7
with primary viral pneumonia	7
it has been suggested	7
as one of the	7
important to note that	7
in the etiology of	7
may be of value	7
with cap admitted to	7
infection of the respiratory	7
for those intolerant of	7
high risk of complications	7
in the tracheobronchial tree	7
in children with community	7
the type of causative	7
the development of resistance	7
integrated management of childhood	7
or the presence of	7
institute of tropical medicine	7
in patients presenting with	7
therapy with a macrolide	7
testing for respiratory viruses	7
can be treated with	7
with a score of	7
especially in patients with	7
it is possible to	7
of mycoplasma pneumoniae infection	7
in children hospitalized with	7
risk factors for aspiration	7
streptococcus pneumoniae and haemophilus	7
be combined with a	7
associated with an increased	7
day or g twice	7
respiratory viruses in adults	7
the lack of a	7
of the lack of	7
committee to prepare the	7
should be included in	7
detection of influenza a	7
in liver disease patients	7
a total of patients	7
with severe adv pneumonia	7
associated with a high	7
r o o f	7
caused by influenza virus	7
as the gold standard	7
into the tracheobronchial tree	7
attributable mortality of ventilator	7
it is clear that	7
in chronic obstructive pulmonary	7
patients hospitalized with influenza	7
respiratory and critical care	7
for invasive pneumococcal disease	7
the severe acute respiratory	7
of adult patients admitted	7
pneumonia in intensive care	7
infectious diseases in the	7
management of respiratory tract	7
guidelines for the treatment	7
made on the basis	7
must also be considered	7
to collapse when the	7
patients with bacterial pneumonia	7
when there is a	7
between children with pneumococcal	7
from the centers for	7
of disease caused by	7
completely improved within days	7
human beings and animals	7
of the lung and	7
of respiratory infections in	7
an antimicrobial activity against	7
of viral and bacterial	7
np carriage of serotype	7
which is characterized by	7
once a day for	7
was no difference in	7
bovine pulmonary edema and	7
prepare the guidelines for	7
the need for intensive	7
of severe adv pneumonia	7
pneumonia in children with	7
analysis of randomized controlled	7
pneumonia infectious diseases society	7
acquired pneumonia severe community	7
risk factors for mortality	7
clinical diagnosis of pneumonia	7
at least one virus	7
is caused by the	7
american thoracic society guidelines	7
obtained from all patients	7
between pneumococcal pneumonia and	7
should be selected as	7
collapse when the thorax	7
the most frequent cause	7
with acute lower respiratory	7
in human beings and	7
it is not necessary	7
a macrolide to a	7
and outcomes in elderly	7
who are unable to	7
is defined as pneumonia	7
lower respiratory tract in	7
for mechanical ventilation and	7
be collected and a	7
had a sensitivity of	7
and colleagues found that	7
pneumonia is the most	7
in children with asthma	7
with names such as	7
of respiratory and critical	7
with aspiration risk factors	7
in the interpretation of	6
between bacterial and viral	6
pneumococcal infections in adults	6
at increased risk for	6
health care of china	6
disease or modifying factors	6
paediatric chest radiographs for	6
no significant difference in	6
with special reference to	6
evaluation of a rapid	6
particularly in patients with	6
less than mm hg	6
has also been described	6
is the most frequent	6
are regarded as having	6
viral pneumonia in children	6
a recent systematic review	6
the identification of a	6
differential diagnosis of pneumonia	6
it is one of	6
was obtained from all	6
should be considered if	6
of antibiotic administration and	6
estimate of the incidence	6
blood cultures to the	6
for viral and bacterial	6
and length of hospital	6
type ii pneumonocytes and	6
pneumonia among children in	6
a lower respiratory tract	6
and a review of	6
single or multiple nodules	6
tests with fdr correction	6
a much lesser extent	6
square tests of proportions	6
viral respiratory tract infections	6
studies have evaluated the	6
detection of bacterial pathogens	6
are beyond the scope	6
the department of health	6
the use of antibiotics	6
the diagnosis is confirmed	6
antibiotic therapy lowers mortality	6
common cause of death	6
diseases in children in	6
the major cause of	6
of viral pneumonia in	6
the absence of an	6
after the introduction of	6
with or without a	6
to first antibiotic dose	6
this study was to	6
of pneumonia in patients	6
prise en charge des	6
a high incidence of	6
a significant reduction in	6
it is now recognized	6
of the medical sciences	6
the treatment of the	6
or vasopressor support in	6
in children with bacterial	6
have been found to	6
not less than seven	6
approved by the institutional	6
bacteremic pneumococcal infections in	6
present in the nasal	6
in children years of	6
there may be a	6
and writing of the	6
on the epidemiology of	6
acquired lower respiratory tract	6
in patients with respiratory	6
administration and outcomes for	6
the first year of	6
infection in young children	6
without risk factors for	6
are applied on the	6
diagnosis can be made	6
the most frequently isolated	6
to identify pneumonia and	6
segment of the lower	6
the viral pneumonia group	6
american journal of the	6
the use of corticosteroids	6
characteristics and classification of	6
clinical features of pneumonia	6
occurs in patients with	6
respiratory syncytial virus is	6
the cause of death	6
liver disease patients with	6
reverse transcriptase polymerase chain	6
management of adult patients	6
respiratory failure due to	6
prospective study of community	6
type b conjugate vaccination	6
in children who are	6
is discussed in chapter	6
the patient was diagnosed	6
is associated with lower	6
pneumococcal pneumonia in the	6
the most common radiographic	6
positive blood culture results	6
be suboptimal for severe	6
of death from infectious	6
journal of the medical	6
medicare patients hospitalized with	6
may also be seen	6
associated with a higher	6
in the caudal lobes	6
in children in developing	6
switch to oral therapy	6
direct et la culture	6
antibiotic treatment is commenced	6
the contribution of blood	6
over years of age	6
a higher incidence of	6
the pathogenesis of the	6
treatment of influenza a	6
children admitted to hospital	6
the diagnostic accuracy of	6
neutral with regard to	6
to of patients with	6
noninvasive positive pressure ventilation	6
and classification of the	6
of the british thoracic	6
onset of symptoms to	6
for diagnosis of community	6
with regard to jurisdictional	6
pneumonia is a leading	6
over h or more	6
of in vitro resistance	6
is consistent with the	6
in the upper airway	6
as an adjunct to	6
pneumonia in young children	6
is often associated with	6
in pediatric intensive care	6
in one study of	6
more frequently identified in	6
au cours des pac	6
medical intensive care unit	6
patients with chronic obstructive	6
mortality in the united	6
are summarized in box	6
acute lung injury and	6
in patients with hiv	6
been proven to be	6
pneumonia as a cause	6
severely ill patients with	6
may be difficult to	6
and should be considered	6
lower respiratory tract samples	6
jurisdictional claims in published	6
is a common disease	6
within the previous months	6
for respiratory syncytial virus	6
even in the presence	6
antibiotic treatment in patients	6
associated with higher mortality	6
the majority of cases	6
administration of cidofovir in	6
in children admitted to	6
the most common finding	6
a reduction in the	6
defined as the presence	6
and the development of	6
suboptimal for severe bacteremic	6
therapy should be administered	6
and infectious diseases society	6
many as of patients	6
a risk of multi	6
addition of a macrolide	6
remains neutral with regard	6
in children with aids	6
is estimated to be	6
total wbc count ml	6
patients admitted to an	6
the management of adult	6
monotherapy may be suboptimal	6
patients with other comorbidities	6
pneumonia in the very	6
springer nature remains neutral	6
therapy should be performed	6
more common in patients	6
been shown to have	6
is not limited to	6
was no significant difference	6
the efficacy and safety	6
national institutes of health	6
because of the lack	6
and child health care	6
in patients infected with	6
patients at risk for	6
the purpose of this	6
in the detection of	6
may play a role	6
type of causative microorganisms	6
journal of respiratory and	6
infections in patients with	6
an improvement in clinical	6
diagnosis of bacteremic pneumococcal	6
maps and institutional affiliations	6
acute respiratory syndrome in	6
patients should be treated	6
are one of the	6
lower respiratory tract is	6
the cause of pneumonia	6
referred to as the	6
in addition to a	6
of the most frequent	6
in the number of	6
exacerbations of chronic bronchitis	6
than patients without pneumonia	6
systematic review of the	6
in adults by using	6
a cause of pneumonia	6
is much more common	6
there is no risk	6
were obtained in exp	6
of noninvasive positive pressure	6
in about of patients	6
the hemagglutinin and neuraminidase	6
skin and soft tissue	6
such as cystic fibrosis	6
infections in adults by	6
have been described in	6
clinical management of adult	6
pneumonia was associated with	6
acquired pneumonia in europe	6
to respiratory failure and	6
was detected in of	6
report and review of	6
of parapneumonic effusions in	6
standardized interpretation of paediatric	6
most commonly seen in	6
severe pneumonia caused by	6
causes of pneumonia in	6
reduce the number of	6
continuous positive airway pressure	6
is most commonly seen	6
patients with pneumonia and	6
of the infectious diseases	6
adults guidelines for the	6
drug is contraindicated for	6
year prospective study of	6
and the lack of	6
with acute respiratory distress	6
present in up to	6
of blood cultures to	6
the southwestern united states	6
heat and damp excreting	6
and polymerase chain reaction	6
in an intensive care	6
has the potential to	6
there have been no	6
in the alveolar space	6
in the first hours	6
in patients with underlying	6
with air bronchogram inside	6
be diffi cult to	6
of acute respiratory infections	6
tests for the diagnosis	6
a predilection for the	6
to be due to	6
antibiotic administration and outcomes	6
transcriptase polymerase chain reaction	6
posterior segments of the	6
early administration of cidofovir	6
as early as possible	6
childhood pneumonia in the	6
in the evaluation of	6
in the neonatal period	6
the second most common	6
for community acquired pneumonia	6
similar results were obtained	6
published maps and institutional	6
of patients with acute	6
to the onset of	6
of bacteremic pneumococcal infections	6
g tds iv or	6
cardiopulmonary disease or modifying	6
study reported that the	6
of avian influenza a	6
common causes of pneumonia	6
the pediatric intensive care	6
acquired pneumonia in spain	6
to detect respiratory viruses	6
the diagnosis of pulmonary	6
an alternative to the	6
a higher risk of	6
and the american thoracic	6
treatment a first choices	6
patients with severe adv	6
regard to jurisdictional claims	6
of the above regimens	6
of the number of	6
for etiologic diagnosis of	6
disease patients with cirrhosis	6
the cdc epic study	6
isolates were resistant to	6
an independent predictor of	6
the diagnosis of bacterial	6
the gross lesions are	6
rapid diagnosis of bacteremic	6
the thoracic cavity is	6
bacterial and viral infections	6
at the site of	6
the most common organisms	6
are included in the	6
for all patients with	6
case report and review	6
pneumonia in the community	6
of the right lower	6
in the four prefectures	6
our data suggest that	6
to a much lesser	6
disease caused by a	6
using the binax now	6
patients with human immunodeficiency	6
a recent study of	6
has been used for	6
least one of the	6
a and b virus	6
for respiratory viruses in	6
such as those with	6
the use of antimicrobial	6
is no risk of	6
pneumonia has not been	6
of comprehensive molecular testing	6
be seen by a	6
therapy lowers mortality among	6
used to assess the	6
pneumonia is an infection	6
chez les patients ayant	6
viral lower respiratory tract	6
should be taken into	6
the clinical significance of	6
of the nasal mucosa	6
a h n infection	6
of pneumococcal pneumonia among	6
should be administered within	6
caused by adenovirus type	6
when the patient is	6
empiric therapy should be	6
of child mortality in	6
nature remains neutral with	6
is closely related to	6
would like to thank	6
which there is no	6
of this type of	6
the pneumonia etiology research	6
management of adult lower	6
is required for the	6
or a combination of	6
low risk of death	6
pneumococcal conjugate vaccine against	6
adults admitted to hospital	6
on the death certificate	6
at mg kg day	6
is the lack of	6
who are at risk	6
most patients can be	6
has been identified as	6
of a macrolide to	6
type of microorganisms that	6
the type of microorganisms	6
contributor in writing the	6
before antibiotic treatment is	6
hospitalized children with pneumonia	6
as an alternative to	6
and outcomes for medicare	6
it is associated with	6
with the advent of	6
the site of infection	6
as soon as possible	6
this study was approved	6
the risk of infection	6
are referred to as	6
writing of the manuscript	6
and negative likelihood ratio	6
clinical features of influenza	6
a tool for predicting	6
one of the major	6
is defined as a	6
to jurisdictional claims in	6
interpretation of paediatric chest	6
controlled clinical trial of	6
the mean roc auc	6
pneumoniae and chlamydia pneumoniae	6
cultures to the clinical	6
it is characterized by	6
to be infected with	6
the hospital with community	6
do not have a	6
combination antibiotic therapy lowers	6
of the lungs are	6
in those with chronic	6
acute respiratory infections in	6
factors associated with pneumonia	6
pneumonia in adult outpatients	6
therapy was associated with	6
to the clinical management	6
it is reasonable to	6
incidence and mortality in	6
classified into two types	6
should always be considered	6
pneumonia in adult patients	6
cd and cd t	6
adults by using the	6
is important to emphasize	6
patients at low risk	6
used to evaluate the	6
in england and wales	6
the performance of the	6
aetiology of childhood pneumonia	6
in bronchoalveolar lavage fluid	6
was defined as the	6
global burden of childhood	6
in the process of	6
of pneumonia due to	6
the ability of the	6
written informed consent was	6
for predicting the need	6
management of adults referred	6
of respiratory viral infections	6
symptoms such as fever	6
drug should be continued	6
the total number of	6
viral pneumonia in older	6
rapid urinary antigen test	6
also been reported in	6
in published maps and	6
be administered for months	6
tuberculosis in the united	6
exacerbation of chronic obstructive	6
should be used as	6
the leading causes of	6
etiologic diagnosis of pneumonia	6
common cause of pneumonia	6
for acute lung injury	6
with underlying lung disease	6
has been used to	6
that can be used	6
in health and disease	6
child health care of	6
licensed in the uk	6
at high risk for	6
and erythrocyte sedimentation rate	6
timing of antibiotic administration	6
outcomes for medicare patients	6
immune response to the	6
appearance is that of	6
clinical management of adults	6
caused by aspiration of	6
caused by influenza a	6
of upper respiratory tract	6
of the cases of	6
should be sent for	6
for treatment of community	6
tool for predicting the	6
infection of the lower	6
important to emphasize that	6
identification of pneumonia and	6
the bacterial pneumonia group	6
of acute interstitial pneumonia	6
of the following criteria	6
the diagnostic utility of	6
and is characterized by	6
at low risk of	6
there has been a	6
claims in published maps	6
of pneumonia in epidemiological	6
incidence and severity of	6
influenzae type b conjugate	6
should be based on	6
contribution of blood cultures	6
were included in the	6
symptoms such as cough	6
severe pneumococcal pneumonia in	6
has been suggested that	6
adult patients with severe	6
in lung transplant recipients	6
and mortality of pneumonia	6
be managed in the	6
of paediatric chest radiographs	6
did not differ significantly	6
in a study of	6
severity of the disease	6
who have a curb	6
pneumoniae detection by blood	6
all cases of pneumonia	6
for elderly patients with	6
there has been no	6
received antibiotics prior to	6
of pneumonia in adults	6
who do not require	6
it is recommended that	6
and the degree of	6
leading to respiratory failure	6
the medical records of	6
by using the binax	6
pneumonia group than in	6
is now recognized that	6
for diagnosis of pneumonia	6
of adult lower respiratory	6
the right upper lobe	6
the setting of a	6
results of a prospective	6
phase of the disease	6
read and approved the	6
and approved the final	6
were excluded from the	6
to mg twice a	6
of pneumococcal conjugate vaccine	6
of antimicrobial therapy in	6
american journal of respiratory	6
days after onset of	6
the annual incidence of	6
introduction of pneumococcal conjugate	6
diagnosis of pneumonia was	6
for use in the	6
the mortality rate was	6
in immunocompromised patients with	6
clinical pulmonary infection score	6
less than seven days	6
the nasal cavity of	6
on gram staining of	6
the most important of	6
economic burden of community	6
be kept in mind	6
pneumoniae and legionella pneumophila	6
and severity of illness	6
detection of viral rna	6
with and without pneumonia	6
residents of nursing homes	6
for medicare patients hospitalized	6
also associated with a	6
percentage of patients with	5
are at risk of	5
started by combining two	5
acid amplification tests for	5
pleural effusions are uncommon	5
to the administration method	5
and a specificity of	5
of pandemic influenza a	5
bacterial pneumonia group than	5
initial antibiotic therapy is	5
in patients with mild	5
this chapter will focus	5
commonly caused by s	5
drug susceptibility and pharmacokinetics	5
may be useful to	5
in young children in	5
empiric antibiotic therapy for	5
be considered as a	5
direct admission to an	5
tract infections caused by	5
fields are demonstrated with	5
about the lung microbiome	5
considering drug susceptibility and	5
pneumococcal infection in adults	5
presence of risk factors	5
patients should be offered	5
the japanese association for	5
syncytial virus infections in	5
are admitted to the	5
shown to be the	5
the th day after	5
a higher rate of	5
is part of the	5
of nursing and healthcare	5
pneumocystis carinii pneumonia in	5
in patients with sepsis	5
reproductive and respiratory syndrome	5
the incidence of clinical	5
analysis was performed using	5
these findings suggest that	5
the primary care operational	5
risk factors for p	5
viral from bacterial pneumonia	5
after a median of	5
significant differences in the	5
conjugate vaccine in children	5
who were diagnosed with	5
strategies for management of	5
lower lung fields and	5
pneumonia in the immunocompromised	5
simplified acute physiology score	5
pneumoniae antigen in urine	5
pneumonia rapid diagnosis of	5
initiation of antibiotic therapy	5
urinary antigen in a	5
pneumonia and bronchial pneumonia	5
with pneumonia caused by	5
global estimate of the	5
group and comorbidity status	5
viral upper respiratory tract	5
the center of the	5
is demonstrated as thickened	5
polymerase chain reaction in	5
such as pasteurella multocida	5
with a focus on	5
for at least one	5
for those with severe	5
lung disease in the	5
polymerase chain reaction testing	5
most common bacterial cause	5
from lower respiratory tract	5
would be expected to	5
pneumonia is an important	5
aspiration pneumonia is suspected	5
new quinolones should be	5
of the clinical features	5
the diagnosis of acute	5
or as a result	5
a high degree of	5
or may not be	5
are characterized by a	5
has been used in	5
of the disease and	5
the discriminant abilities of	5
is difficult to establish	5
or laboratory data is	5
an analysis of the	5
xpert mtb rif assay	5
advice on antipyretics and	5
adult patients with pneumonia	5
it should be considered	5
was supported by nih	5
the case of the	5
those in whom the	5
over the age of	5
porcine reproductive and respiratory	5
risk factors and causative	5
lung aspiration for the	5
ill patients with pneumococcal	5
pneumonia from chest x	5
patients who present with	5
and the acute respiratory	5
on the chest radiograph	5
identical to those of	5
in the most severe	5
rapid immunochromatographic test for	5
higher in children with	5
and etiology of community	5
the lung fields are	5
for at least days	5
with the appearance of	5
hospitalized patients with pneumonia	5
under a tentative diagnosis	5
respiratory viruses in the	5
of hospitalized cap patients	5
and the detection of	5
it has been estimated	5
distention of the interlobular	5
microorganisms that caused pneumonia	5
associated with adenovirus type	5
pneumonia caused by adenovirus	5
is shown in table	5
viral infections such as	5
should be started by	5
treatment of hospitalized patients	5
is present in the	5
infiltrate on a chest	5
and can be used	5
within hours of intubation	5
care testing for respiratory	5
pneumonia in cirrhotic patients	5
of children with pneumococcal	5
new and emerging etiologies	5
the possibility of an	5
had a positive blood	5
of neutrophils in bal	5
pneumonia among children under	5
adults hospitalized with laboratory	5
or those in whom	5
treatment of lower respiratory	5
severe respiratory syncytial virus	5
patients with mild to	5
severe acute respiratory distress	5
pneumoniae and its role	5
the respiratory tract of	5
the most commonly used	5
should be reserved as	5
the most severe cases	5
such as respiratory syncytial	5
the massachusetts general hospital	5
septic shock requiring vasopressors	5
no conflicts of interest	5
may lead to the	5
or a bacterial pneumonia	5
at risk for infection	5
be found in the	5
stain and culture of	5
on antipyretics and fluids	5
in the winter months	5
patients with h n	5
it must be considered	5
of pediatric parapneumonic empyema	5
of the children were	5
by polymerase chain reaction	5
of proportions with continuity	5
approximately one third of	5
in hospitalized infants with	5
patients who were diagnosed	5
regions of the world	5
the presence of specific	5
at risk of complications	5
of pneumonia is not	5
pneumoniae isolates were resistant	5
now assay for detection	5
in cases of influenza	5
for more than of	5
to identify patients with	5
although there is no	5
lung fields are demonstrated	5
treatment and prevention of	5
a variety of other	5
pneumonia due to gram	5
appears to be the	5
identified in patients with	5
detect the presence of	5
proliferation of type ii	5
yield with new diagnostic	5
of cap in adults	5
practice of infectious diseases	5
e mg kg twice	5
sequential organ failure assessment	5
and the absence of	5
the same antimicrobial drug	5
pathogens and antibiotic resistance	5
type a influenza virus	5
increased risk of pneumonia	5
systematic review and metaanalysis	5
patients admitted with community	5
the diagnosis of covid	5
viral infection in community	5
in a cohort of	5
and viral pneumonia in	5
that caused pneumonia is	5
the likelihood of infection	5
in the light of	5
hypoxaemia in children with	5
as the number of	5
of a rapid immunochromatographic	5
may be responsible for	5
pneumonia among adults in	5
among patients hospitalized with	5
increases the risk of	5
should be assessed for	5
initial antimicrobial drug therapy	5
use of antibiotics and	5
pneumonia should be treated	5
next manuscript to biomed	5
pediatric intensive care units	5
both upper and lower	5
several studies have shown	5
approved by the ethics	5
lesions in the lungs	5
the result of an	5
between months and years	5
the length of stay	5
diagnosis of the etiology	5
has not been reached	5
the nasal mucosa is	5
at the early stages	5
the ministry of health	5
on clinical outcomes in	5
in the nasal mucosa	5
of pediatric infectious diseases	5
outbreak of acute respiratory	5
pneumonia in the united	5
hospitalized patients with severe	5
the onset of pneumonia	5
to be effective in	5
but not on initial	5
adenovirus type in immunocompetent	5
antibiotic regimen is associated	5
seasonal influenza virus infection	5
and length of stay	5
by combining two drugs	5
due to influenza a	5
factors associated with death	5
children adolescents aged e	5
rates as high as	5
and emerging etiologies for	5
aged between and months	5
patients with chronic lung	5
emerging etiologies for community	5
patients can be adequately	5
of bronchoalveolar lavage fluid	5
the who case definition	5
in the upper lung	5
should be managed as	5
a sensitivity of and	5
in patients with pneumococcal	5
h n influenza pneumonia	5
peripheral blood eosinophilia and	5
early in the disease	5
in adults with community	5
oral care with chlorhexidine	5
in adults in europe	5
can be useful in	5
for infection with unusual	5
all five pneumococcal proteins	5
mortality among severely ill	5
infection control practices advisory	5
the diagnosis of cap	5
management of cap in	5
a chest radiograph is	5
of pneumonia in which	5
with a sensitivity of	5
rapid diagnosis of influenza	5
by the ethics committee	5
negative bacteria and pseudomonas	5
immunology of viral pneumonia	5
to discriminate between pneumococcal	5
the respiratory tract is	5
the presence of these	5
acute exacerbation of chronic	5
tests of proportions with	5
and antimicrobial susceptibility tests	5
and as a result	5
age of the patient	5
la pcr pour le	5
vasopressor support in community	5
clarithromycin mg bd b	5
also been described in	5
pneumonia in children younger	5
of combination therapy with	5
the highest mean accuracy	5
quinolones should be selected	5
of the united states	5
cystic fibrosis cystic fibrosis	5
it is known that	5
the onset of clinical	5
and thickening of the	5
cause of cough in	5
assay for diagnosis of	5
of acute respiratory distress	5
pneumonia in children is	5
of the immunochromatographic binax	5
adult patients admitted with	5
obtained from the images	5
urine samples from adults	5
symptoms or laboratory data	5
in patients with ventilator	5
may also be present	5
characteristics and outcomes of	5
were found to have	5
adolescents aged e years	5
in the periphery of	5
the most common infections	5
respiratory syncytial virus a	5
be associated with the	5
is found in the	5
the appearance of a	5
immunochromatographic test for detection	5
was associated with reduced	5
continues to be a	5
the national institutes of	5
a definitive diagnosis is	5
a decrease in the	5
for a number of	5
a white blood cell	5
as respiratory syncytial virus	5
risk factors for the	5
to investigate the etiology	5
of clinical pneumonia among	5
sent for gram stain	5
pneumococcal disease in hiv	5
yield of blood cultures	5
posterior segment of the	5
should be given in	5
cause of death field	5
the patient has a	5
antibiotic therapy for ventilator	5
of the risk of	5
been previously reported in	5
in the differentiation of	5
in the later stages	5
infiltrates on chest radiography	5
contraindicated for pregnant women	5
guidelines for the prevention	5
a result of the	5
a high risk of	5
pneumonia in children aged	5
after initiation of antibiotic	5
may be more common	5
antimicrobial activity of the	5
older than years of	5
the risk factors for	5
less than months of	5
comprehensive molecular testing was	5
with high uniform density	5
the most frequently identified	5
of neuraminidase inhibitors in	5
continuity and fdr correction	5
within the first h	5
available in the first	5
pneumonia can occur in	5
in the study design	5
as a diagnostic tool	5
the start of treatment	5
factors and causative pathogens	5
against pneumococcal pneumonia in	5
treatment of children with	5
by means of a	5
the number one cause	5
appears to be a	5
with a poor outcome	5
should be guided by	5
respiratory tract infections caused	5
children hospitalized with pneumonia	5
to that seen in	5
in intubated patients with	5
of pneumonia in a	5
is less likely to	5
of bal fluid total	5
type and severity of	5
predicting bacteremia in patients	5
severe pneumonia in children	5
adults referred to hospital	5
as pseudomonas aeruginosa and	5
association for infectious diseases	5
acquired pneumonia with implications	5
the treatment of acute	5
showed a ph of	5
combination with a macrolide	5
lactam plus an aminoglycoside	5
much more common in	5
there is a high	5
interstitial pneumonia and bronchial	5
empirical antibiotic regimen is	5
primary care operational plan	5
patients with aspiration risk	5
respiratory quinolones should be	5
authors read and approved	5
tract infections in the	5
neutrophils in bal fluid	5
it is not easy	5
type i and ii	5
in patients with influenza	5
are most likely to	5
neoplasms of the lungs	5
the etiological diagnosis of	5
type in immunocompetent adults	5
in only to of	5
for rapid diagnosis of	5
should be made to	5
pneumonia secondary to other	5
than in the viral	5
of the chest radiograph	5
pneumonia in the tropics	5
the treatment of choice	5
in bal fluid is	5
standards of care committee	5
from a variety of	5
lung injury and the	5
lymphocytes and plasma cells	5
those with severe illness	5
the oral administration of	5
based empirical antibiotic regimen	5
a and b in	5
the need for hospitalization	5
a short period of	5
in patients with bacteremic	5
tuberculosis should be considered	5
acquired pneumonia evaluation of	5
duration of antibiotic therapy	5
at least two of	5
patients with cap in	5
if an improvement in	5
by streptococcus pneumoniae in	5
binax now assay for	5
exacerbation of chronic bronchitis	5
of the study and	5
the role of corticosteroids	5
the impact of influenza	5
with the severity of	5
was a contributor in	5
are not specific for	5
be noted that the	5
for patients hospitalized with	5
in urine samples from	5
in the event of	5
pathogen has been identified	5
among children aged years	5
of the immune response	5
the diagnosis of lower	5
acute respiratory failure requiring	5
divided into two groups	5
among severely ill patients	5
in children under five	5
regimen is associated with	5
in patients with copd	5
role in the diagnosis	5
plays an important role	5
collected from patients with	5
cases of pandemic influenza	5
the context of pneumonia	5
may lead to a	5
clinical practice guidelines for	5
risk for infection with	5
at the onset of	5
ct features in patients	5
the pores of kohn	5
be adequately treated with	5
access to health care	5
to maintain oral intake	5
with congenital heart disease	5
of patients hospitalized for	5
there is no specific	5
both influenza a and	5
be sent for gram	5
in the face of	5
the incidence of side	5
most common infections in	5
in europe and the	5
with underlying medical conditions	5
respiratory tract infection is	5
in the elderly population	5
the spectrum of pulmonary	5
children from developing countries	5
patients hospitalized for community	5
de la pcr pour	5
with the formation of	5
a high mortality rate	5
the ethics committee of	5
it is an important	5
effect of corticosteroids on	5
microbiological yield with new	5
with continuity and fdr	5
of pyothorax is made	5
are the result of	5
extracorporeal membrane oxygenation for	5
is the number of	5
lung fields and around	5
for patients with community	5
etiology of severe pneumonia	5
scattered throughout the lungs	5
of acute pneumonia in	5
effectiveness of pneumococcal polysaccharide	5
in children in japan	5
drug susceptibility are clarified	5
influenzae type b and	5
of death among children	5
resistance to penicillin and	5
should be selected through	5
are involved in the	5
occur in patients with	5
clinical and radiographic features	5
patchy areas of consolidation	5
diagnosis of mycoplasma pneumoniae	5
pneumonia requiring mechanical ventilation	5
systemic inflammatory response syndrome	5
role in the development	5
to hospital pandemic flu	5
study of consecutive patients	5
factors for the development	5
a prospective randomised study	5
of microorganisms that caused	5
the emergence of a	5
significant morbidity and mortality	5
a tentative diagnosis of	5
with implications for therapy	5
therapy for hospitalized patients	5
seen in children with	5
data s and s	5
management of nursing and	5
two of the following	5
the results of culture	5
with mild to moderate	5
within the first hours	5
a macrolide or a	5
treatment of aspiration pneumonia	5
cause of cap in	5
acute exacerbations of chronic	5
caused pneumonia is identified	5
portions of the lung	5
considered for treatment with	5